RenovoRx Announces the U.S. Patent and Trademark Office Issuance of Two Patents
RenovoRx, a leading developer of innovative solutions for targeted therapy today announced that the company has received two new device patents, Devices Methods and Kits for Delivery of Therapeutic Materials to a Target Artery (U.S. Patent No. 9,457,171 and U.S. Patent No. 9,463,304) for its RenovoCath™ delivery catheter. The RenovoCath is indicated for the isolation of blood flow and delivery of fluids, including diagnostic and/or therapeutic agents, to selected sites in the peripheral vasculature system.
RenovoRx Announces the U.S. Patent and Trademark Office Issuance of Two Patents
RenovoRx today announced that the company has received two new device patents, Devices Methods and Kits for Delivery of Therapeutic Materials to a Target Artery (U.S. Patent No. 9,457,171 and U.S. Patent No. 9,463,304) for its RenovoCath™ delivery catheter. The RenovoCath is indicated for the isolation of blood flow and delivery of fluids, including diagnostic and/or therapeutic agents, to selected sites in the peripheral vasculature system.